Related Experiment Video
Updated: May 21, 2026
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary artery flow catheters for directing management in pre-eclampsia
Ying Hong Li1, Natalia Novikova
1Women’s Health and Neonatology, Royal Prince Alfred Hospital, Sydney, Australia.yinghongli168@gmail.com.
The Cochrane Database of Systematic Reviews
|June 15, 2012
Summary
No randomized trials support pulmonary artery catheters for severe pre-eclampsia. More research is needed to manage fluid shifts, preventing renal failure and pulmonary edema in these high-risk pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Critical Care Medicine
- Maternal-Fetal Medicine
Background:
- Gestational hypertension and pre-eclampsia can lead to dangerous fluid shifts.
- These fluid shifts may cause pulmonary edema and renal failure.
- Effective fluid management is critical for pre-eclampsia patients, especially those with pulmonary edema and renal failure.
Purpose of the Study:
- To evaluate the safety and effectiveness of pulmonary artery catheters.
- To determine if these catheters can prevent or manage renal failure and pulmonary edema in severe pre-eclampsia.
Main Methods:
- Searched the Cochrane Pregnancy and Childbirth Group's Trials Register.
- Included randomized trials on pulmonary artery catheter use in pre-eclamptic women.
- Searched up to April 30, 2012.
Main Results:
- No randomized controlled studies were identified.
- There are no included studies to analyze.
Conclusions:
- Currently, no evidence from randomized controlled trials supports pulmonary artery catheter use.
- Fluid management in pre-eclampsia, particularly for preventing renal failure and pulmonary edema, remains a significant clinical challenge.
- Further randomized trials are needed, acknowledging the procedural difficulties.
Related Concept Videos
01:21Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...